Menu

Impact Events

More
Date Lead Company Event Type Approval Change Approval Likelihood
11/19/25 Protara (TARA) TARA-002 for Lymphatic Malformation (LM) Subscribers Only Subscribers Only Subscribers Only
11/19/25 Agios Pharmaceuticals (AGIO) Pyrukynd for Sickle Cell Disease Subscribers Only Subscribers Only Subscribers Only
11/19/25 The TB Alliance TBAJ-876 for Tuberculosis Subscribers Only Subscribers Only Subscribers Only
11/17/25 Nuvalent (NUVL) NVL-655 for Non-Small Cell Lung Cancer (NSCLC) Subscribers Only Subscribers Only Subscribers Only
11/17/25 Jazz Pharmaceuticals (JAZZ) Ziihera for Gastric Cancer Subscribers Only Subscribers Only Subscribers Only

Upcoming Catalysts

More
Expected Date Range Lead Company Drug Expected Catalyst
05/09/2019 Subscribers Only Subscribers Only Trial Data - Other
01/31/2025 Subscribers Only Subscribers Only Trial Announcement - Initiation
01/31/2025 Subscribers Only Subscribers Only Trial Announcement - Initiation
06/25/2025 Subscribers Only Subscribers Only Company - Analyst/R&D Update
06/25/2025 Subscribers Only Subscribers Only Company - Analyst/R&D Update